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Abstract:
Vibrational spectroscopy, based on either infrared absorption or Raman scattering, has attracted
increasing attention for biomedical applications. Proof of concept explorations for diagnosis of oral
potentially malignant disorders and cancer are reviewed, and recent advances critically appraised.
Specific examples of applications of Raman microspectroscopy for analysis of histological, cytological
and saliva samples are presented for illustrative purposes, and the future prospects, ultimately for
routine, chairside in vivo screening are discussed.
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1. Introduction
Oral cancers are prevalent worldwide, and, in 2018, had estimated age-standardised incidence rate
(World) for both sexes, all ages, of 4 per 100,000 population [1]. Critically, carcinoma of the oral
cavity has a very poor overall 5 year survival rate of approximately 50%, due mostly to late stage
diagnosis [2]. Oral squamous cell carcinoma (OSCC) is the predominant malignancy and is more
common in males than females, having a ratio of 1.5:1, and in older persons (aged 50 or over) [3].
Nevertheless, there are currently changes in the trend, manifest as an increase in incidence in young
persons, which may be due to HPV infection as opposed to the traditional risk factors such as
smoking and tobacco [4].
OSCC arises in the squamous epithelium and, like all cancers, is a multi-step process in which cells
acquire mutations that allow them to evade immune surveillance and divide uncontrollably. It can
manifest as an endophytic (inward) or exophytic (outward) growth, which can either arise de novo or
from oral potentially malignant disorders (OPMD), typically either from a leukoplakia (white plaques
of questionable risk having excluded (other) known diseases or disorders that carry no increased risk
for cancer), erythroplakia (red patch) or erythroleukoplakia (mixed red and white patch) [5]. Most

OPMD are symptomless, but some may be associated with bleeding, or soreness. The risk of
malignant transformation of these OPMD is determined by a numbers of factors, with the degree of
dysplasia being the most significant. The current recommendation for management of OMPDs is that
risk factors are addressed and moderate and severely dysplastic oral lesions are excised, while
OPMD with no dysplasia is usually followed up annually, mild dysplasia reviewed every 6-12 months
OSCC usually present clinically as a persistent ulcer or hard lump in the oral mucosa, but leukoplakias,
erythroplakias and erythroleukoplakias may be found, on biopsy, to harbour OSCC. Patients with
advanced OSCC may present with symptoms like difficulty of swallowing or speaking, or swollen lymph
nodes in the neck [6]. Following appropriate referral, any suspicious lesion is biopsied and sent for
histopathological examination, which is the gold standard for oral cancer diagnosis. After the initial
diagnosis of OSCC is made, the cancer staging to determine the tumour size, presence of lymph node
or distant metastasis is determined by the use of imaging techniques such as MRI, CT, and PET scans
[7]. Cancer stage at diagnosis is the single most important prognostic factor.
Early diagnosis is therefore critical in the management of oral cancer, [8].The low rate of early
diagnosis of OSCC can be partially attributed to the late recognition of such OPMDs prior to
malignant transformation [9, 10]. Visual observation of mucosal abnormalities by a dentist or
hygienist is the most common starting point of diagnosis, and therefore optical methods play a
potential role, currently, and in prospective advances in methodologies for early stage diagnosis
[11]. In particular, the vibrational spectroscopic techniques of infrared (IR) absorption and Raman
scattering spectroscopies promise the potential for objective, label free, in vivo or ex vivo analysis,
which is based on the molecular content of the sample, rather than simply the morphological
appearance of abnormalities, a process which can be highly subjective.
This paper describes research efforts towards the development and validation of vibrational
spectroscopic methods, typically employing commercially available spectroscopic instrumentation,
for the early identification of abnormalities in the oral cavity in tissue, cells and saliva, reviewing
literature to date. Specific examples of the application of Raman microspectroscopy, based on work
of the authors, are presented. Future perspectives are presented, also in the context of the potential
of the technique for in vivo screening and monitoring.
2. Histopathology
Both IR and Raman spectroscopies provide a biochemical “fingerprint” of the sample under
interrogation, on the basis of the distinctive vibrations of the constituent molecules. They are,
however, fundamentally different techniques, as evidenced starkly by the fact that, while Raman
spectroscopy is commonly carried out in the visible or near infrared region of the spectrum, IR
spectroscopy is commonly carried out in the mid-infrared region. Both can be carried out in the
microscopic mode (for further information and comparison of methodologies, see for example [12]),
in which, intrinsic limitations to spatial resolution imply that Raman can probe areas of <1 m,
whereas IR is typically limited to ~10 m. In the field of spectro-histopathology [13], however, the
requirement to rapidly scan large areas of tissue probably currently favour the use of IR rather than
Raman spectroscopy.
A number of early stage studies demonstrated that Fourier Transform IR (FTIR) microspectroscopy,
can be employed to effectively differentiate abnormal and normal states in excised oral tissues, and
pointed towards the differences in biochemical composition underpinning the differentiation.
Schultz et al. [14] undertook a study which attempted to identify the biochemical differences
between well and poorly differentiated oral/oropharyngeal SCC, and demonstrated that spectral
features of DNA and keratin can provide the basis for differentiation of clinically classified normal
and OSCC biopsies. The prominence of keratin structures in OSCC samples was also explored [15].
Wu et al. [16] demonstrated that normal and malignant oral tissues can be discriminated on the
basis of the relative lipid and protein content of fresh oral tissue samples. Comparing tissue from

normal subgingival sites and OSCC, Fukuyama et al. [17] demonstrated that the spectral
characteristics of normal tissue are more strongly influenced by contributions of keratin and
collagen, compared to the spectra of abnormal samples. Increasingly sophisticated FTIR
spectroscopic imaging methods have provided the capacity to explore different aspects of oral
cancer and cancer development. By generating 3D infrared chemical maps, Bruni et al. [18] showed
that proliferating and regressive states of head and neck tumours can be identified. A study using
FTIR spectroscopy to explore chemopreventive effects of drug-loaded nanoparticles on oral
carcinogenesis in animal models has also been reported [19].
Applications of Raman spectroscopy in oral cancer diagnostics began with the analysis of normal and
dysplastic tissue in a rat model by Bakker Schut et al. [20], who achieved sensitivity and specificity of
100% for dysplasia induced in the palate by topical application of the carcinogen 4-nitroquinoline 1oxide. There followed a study of human oral cancer biopsies by Venkatakrishna et al. [21] who
obtained an average classification efficiency of 88%. A study carried out by Krishna et al. in 2004 [21]
demonstrated the applicability of formalin-fixed oral tissues for optical pathology, revealing
significant differences in the epithelial region of normal and malignant samples, arising from the
protein composition, conformational/structural changes, and possible increase in protein content in
malignant epithelia. In 2006, Malini et al. [22] demonstrated the efficacy of Raman spectroscopic
methods in discriminating normal, cancerous, precancerous, and inflammatory conditions. Lipid rich
features in normal conditions and prominent protein features in tumours and other pathological
conditions were observed. Classification between different groups using multivariate statistical
methods produced 100% sensitivity and specificity [22]. Raman mapping of tissue sections further
elucidated biochemical changes within different epithelial layers, which are associated with disease
onset [23, 24]. A study by Sunder et al. [25] demonstrated that oral carcinomas of different
pathological grades can also be differentiated on the basis of the relative intensities of bands
associated with lipids and proteins.
Cals et al. undertook a study of excised tongue tissue samples (11 OCSCC and 14 normal) of 10
patients, to establish multivariate classification models based on Principal Components Analysis
(PCA) – Linear Discriminant Analysis (LDA), a binary tumour versus non-tumorous tissue model
showing an accuracy of 91%, sensitivity of 100%, and specificity of 78% [26]. A further study
specifically explored samples of OSCC from excised tongue tissue (44 samples from 21 patients) and
produced a range of anatomically subclassified spectra, characteristic of OSCC, surface squamous
epithelium, muscle, adipose tissue, connective tissue, gland, and nerve [27]. Least squares fitting
each characteristic spectrum with combinations of biochemical constituent spectra revealed that the
carbohydrates, proteins and amino acids content was the strongest discriminator between OSCC and
healthy tissue. Jeng et al. explored the use of Raman microspectroscopy to differentiate excised
tumour and normal tissue samples from different anatomical regions; the tongue, the buccal
mucosa, and the gingiva of the oral mucosa [28]. Although a high degree of classification was
observed for all sites, analysis of the gingiva was seen to yield the highest values of accuracy (91%),
sensitivity (92%) and specificity (91%). In addition to protein and amino acid, variations of betacarotene content were identified as a potential biomolecular marker of oral cancer. Jeng et al.
compared the performance of the classifier algorithms, PCA - LDA and PCA - quadratic discriminant
analysis (QDA), the latter performing better, while Yu et al. applied deep convolutional neural
networks to classify squamous cell carcinoma and non-tumorous tissue of the tongue, achieving high
values of sensitivity (99.31%) and specificity (94.44%) [29].
Although there have been numerous proof-of-concept studies to demonstrate the potential of both
IR and Raman spectroscopies for spectro-histopathology, an issue which continues to arise is that of
sample presentation [30, 31]. Although unadulterated, fresh tissue biopsies are preferable, the goldstandard histopathological method employs a process of formalin fixation followed by paraffin wax
embedding. The tissue is first dehydrated and then infiltrated with paraffin wax, such that the
samples are stabilised and can be stored for years. These formalin fixed paraffin preserved (FFPP)

archival tissue libraries can potentially be a vast resource for retrospective studies of patient history
and disease progression. Unfortunately, the lipid-like paraffin wax can interfere with either FTIR or
Raman spectroscopic analysis [32, 33]. A number of different approaches to remove the paraffin wax
have been tested. The normal clinical protocols of chemical dewaxing have been demonstrated to be
only partially effective [33], and also dependent on the clinical pathology [34], while so called “digital
dewaxing” has been shown to be only partially successful [35]. Toward high throughput automated
analysis, Pallua et al. [36] demonstrated that high quality FTIR microspectroscopic images can be
obtained from formalin-fixed paraffin-embedded tissue microarray sections, providing molecular
level information as the basis for diagnosis. However, the symmetrical C-C vibrations of the wax
molecule backbone are particularly strong in Raman spectroscopy, and, as the embedded wax is
microcrystalline, and the source laser usually polarised, it has been shown that the difficulties in the
subtraction of the wax contributions to the Raman spectra of tissue are due to the continuous
variability of the spectra [37]. However, by employing a matrix of (300) reference spectra of the wax,
Ibrahim et al. demonstrated the effective removal of its contamination, as well as that of the glass
substrate (Figure 1), from the spectra of both epithelial and connective tissue of oral biopsies (Figure
2) [37].

Figure 1: Mean Raman spectra of epithelial and connective tissue before (left) and after (right)
digital wax removal. Shading denotes the standard deviation [37].

Figure 2: Representative H&E images showing the regions of epithelium (darkly stained) and
connective tissue (lightly stained) [37].

Using the digital processing protocol, Ibrahim explored the potential of vibrational spectroscopy,
specifically Raman, to monitor the early stage progression of oral cancer [38]. OSCC is commonly
preceded by a range of cell and tissue alterations, termed dysplasia, which indicate an increased risk
of malignant transformation. Dysplasia is classified according to severity into mild, moderate,
severe/ carcinoma in situ. The initial study therefore undertook to attempt to discriminate

between mild, moderate and severe dysplasia in FFPP tissues from biopsies of 4 patients who
had undergone multiple biopsies over time [38]. Two maps were taken for each pathology, one
of epithelium and one of connective tissue. Each consisted of 200 spectral points (~1 m) taken
at 10 μm intervals. Using a Partial Least Squares, Discriminant Analysis (PLSDA) approach, high
degrees of sensitivity and specificity were achieved for classification of each grade of dysplasia,
in both tissue regions (Table 1).

Table 1: Sensitivity and specificity values obtained for the PLSDA classification model

Expanding the study to a cohort of 57 patients, the spectroscopic differences between benign,
mild, moderate, severely dysplastic and OSCC FFPP tissues were explored [38, 39]. Although the
sensitivities and specificities for each grade of dysplasia were in some cases rather low (Table 2),
the performance was considerably improved by grouping the mild and moderate groups (Table
3), although clinically, mild is considered low risk while moderate and severe dysplasia are
considered high risk.

Table 2: Sensitivity and specificity values obtained from PLSDA classification of epithelial tissue.

Table 3: PLSDA classification of epithelial tissue combining the mild and moderate groups
As the study was based on a heterogeneous group of patients with different gender, age, habits,
medical histories and lesion clinical features, the relatively poor performance of the discriminative
models prompted an investigation of the potential influence of patient factors and clinical features
on Raman classification, such as smoking, alcohol consumption, and anatomical site Tobacco
smoke contains carcinogens and has a well established role in the development of both
dysplastic [40] and malignant [41] oral lesions. Similarly, alcohol consumption has been
associated with the development of both oral dysplasia [40] and cancer [41]. The incidence of

oral cancer is higher in males than females [42, 43], which is likely due to habits such as smoking
and alcohol consumption rather than a genetic predisposition, although the prognosis is the
same [44]. Gender was not found to have an association with the development of oral dysplastic
lesions [40]. Further variability can arise because of the different sites of anatomical origin of
the lesion. Oral cancer refers to any cancer in the oral cavity proper which includes; the tongue,
labial and buccal mucosa, palate, gingiva, alveolar ridges and floor of the mouth. These areas
vary in degree of keratinisation, vascularity and lymphatic drainage [44] and thus anatomic site
may also influence the spectroscopic signatures upon which a classification is to be based.
Ibrahim et al. used patient metadata to subdivide the sample spectra, regardless of
histopathological diagnosis, into groups according to gender, smoking habits, alcohol
consumption and site of lesion [39]. The analysis indicated no discrimination based on gender, or
alcohol consumption. Although the lesions came from different anatomical sites in the oral cavity,
including the tongue, buccal mucosa, soft palate, hard palate and labial mucosa, the PLSDA
classification results were very varied and inclusive, probably due to the low number of samples
per site, although grouping according to keratinised (tongue and hard palate) and nonkeratinised (soft palate, buccal and labial mucosa) did show some degree of discrimination. A
degree of discrimination was also evident in the epithelia of 3 groups; non-smoker, ex-smokers
(previous smokers) and smokers.
Notably, all the pathologies showed the presence of inflammation, increasingly so with
increasing severity of dysplasia, consistent with a previous study that has shown increasing
inflammatory cell infiltration with increasing severity of oral dysplasia and SCC [45]. PLSDA
indicated a high degree of sensitivity and specificity for discrimination of inflamed vs noninflamed for all the pathologies combined, in both epithelial (68% and 70%), and connective
tissue (77% and 86%). The presence of inflammation in the tumour microenvironment has been
well documented [46, 47] and is due to multiple factors. The environmental factors that prompt
carcinogenesis, such as alcohol and smoking, have been shown to trigger an inflammatory
response [48]. Furthermore, the tumour cells release inflammatory mediators which generate
an inflammatory microenvironment that promotes cancer growth, invasion and metastasis [49].
A study looking at OSCC surgical margins found that inflamed connective tissue was more likely
to misclassify with SCC than non-inflamed connective tissue [50]. The presence of inflammation,
particularly in the connective tissue of biopsies, is therefore potentially the most profound
factor which may confound the diagnostic accuracy of the technique.
3. Cytology:
Oral exfoliative cytology could potentially offer a minimally invasive means of monitoring dysplastic
lesions in the oral cavity. Dysplastic and cancerous cells tend to have fewer and weaker connections
to each other and to their neighbouring normal cells in the surrounding tissue and thus can easily be
collected from the surface of the lesion. Oral brush biopsy is a well-tolerated, minimally invasive and
safe method for harvesting cells from the oral cavity but oral cytology has not been widely adopted
because of poor sensitivity for identification of dysplasia and cancer [51]. Other techniques, such as
DNA analysis and molecular markers, such as melanoma associated antigen A (MAGE-A), lamin-5,
Tenascin-C and epidermal growth factor receptor (EGFR), have been shown to improve the sensitivity
and specificity of oral cytology [52]. In addition, as oral brush biopsy detects only cellular changes, a
surgical biopsy coupled with histopathological assessment must be performed for definitive diagnosis
of oral lesions. While cancerous cells can be collected from the surface, this does not constitute a
diagnosis, which requires histological proof of breach of basement membrane. Despite this, brush
biopsy may be very useful for patients with multiple oral lesions or for monitoring OPMDs

A limited number of FTIR microspectroscopy studies have been reported, demonstrating the feasibility
of diagnosis of oral cancers using single exfoliated cells prepared by cyto-centrifugation onto low e
microscope slides [53–57]. Papamarkakis et al. demonstrated that FTIR microspectroscopy could
classify oral cells according to anatomical site and that the compositional changes were attributed to
the expression of keratins in the cells of the tongue and to the expression of collagen in the cells of
the floor of the mouth [54]. In addition, samples from patients with malignancy associated
abnormalities were observed to be spectrally similar to a sample from a patient with oral squamous
cell carcinoma, and spectrally distinct from samples from healthy volunteers. Spectral differences in
oral cells infected with the herpes simplex virus were also reported. Further studies from the same
group showed that spectra from exfoliated cells from healthy volunteers could be discriminated from
exfoliated cells from patients with oral dysplasia and cancer [55–57].
Similarly, only a limited number of Raman microspectroscopy studies have focussed on oral exfoliated
cells. Sahu et al. [58] demonstrated discrimination between patients with oral cancer and healthy
volunteers based on increased DNA and differences in protein secondary structure using pellets of
oral exfoliated cells and the work was extended to detection of OPMDs [59]. Behl et al. [60] reported
a new method for Raman microspectroscopy of single oral exfoliated cells prepared as liquid based
cytology samples onto glass slides. A complete methodology incorporating sample collection, sample
preparation, spectral acquisition and data pre-processing and analysis was developed (Figure 3).

Figure 3: Optimised protocol for the Raman microspectroscopic study of oral exfoliated cells [60].
Further work by Behl et al. [61] analysed brush biopsy cytological samples from healthy donors and
from patients with OPMDs, leukoplakia, erythroplakia and erythroleukoplakia, showing mild,
moderate or severe dysplasia on histological analysis. Sensitivities of 94% and 86% and specificity of
85% were achieved for discrimination between oral exfoliated cells from healthy donors and from
patients with OPMDs, for spectra recorded from the cytoplasm and nucleus respectively, as shown in
Figure 4, for the example of cytoplasm.

Figure 4: PLS-DA predictive model for cytoplasm (normal vs lesion) a) score plot, b) Latent variable 1,
c) predictive model and d) confusion matrix [61].
The discrimination was observed to be mainly based on lipidic contributions from the OPMD samples.
This could be attributed to the fact that, during cell division, cells need energy, and this requirement
is fulfilled by upregulating the lipid metabolism within the cell. Key spectroscopic features which were
seen to be prominent in the PCA differentiation of healthy donors and from patients with OPMDs are
identifiable in the Raman spectra of palmitic acid and C14-Ceramide (Figure 5). It is known that, if
ceramide synthesis is mediated by a de-novo pathway, it condenses serine and palmitoyl-CoA (betaoxidised form of palmitic acid) as precursors in the endoplasmic reticulum [62]. It was demonstrated
that the differentiating PCA loading, in the region 600-1400 cm-1, could be well fitted by a weighted
difference of the spectra of palmitic acid and C14-Ceramide. Sphingolipids such as ceramides and
sphingosine are building blocks for the eukaryotic plasma membrane. They have an important role to
play in intra- or intercellular messengers, signal transduction, inflammation, angiogenesis, metabolic
syndrome, neurodegeneration, and cancer/cancer therapy [63]. In mammalian cells, there are >28
enzymes for ceramide metabolism and about >200 distinct structures. Through this explorative study,
although there are many other contributing factors to the differentiating loading which were not
fitted, it was successfully demonstrated that ceramides may play an important role in the
discrimination of OPMD samples from healthy volunteer samples using Raman microspectroscopy and
could therefore act as a spectral marker. Furthermore, this study also indicated that, in OPMDs,
ceramide concentration increases in the cell, allowing differentiation of healthy volunteer samples
from the OPMD patient samples.

Figure 5: Loading of differentiating principal component for healthy volunteer samples and dysplasia
samples indicating bands at 1065 and 1130 cm-1, also observed in the Raman spectra of C14-ceramide
and palmitic acid
The study also investigated the influence of age, gender, anatomical site, smoking and alcohol
consumption on the classification model. Age, gender, smoking and alcohol consumption were not
found to be confounding factors whereas anatomical site was found to influence the classification
model. Spectra from gingiva and alveolar mucosa were found to be different to spectra from buccal
mucosa and ventral surface of the tongue (Figure 6). As both gingiva and alveolar mucosa are rich in
lipids such as ceramides, saturated fatty acids and cholesterol, which act as an antibacterial barrier
against infection, cells from these sites showed a similar lipidic spectral profile to cells from OPMDs.
Thus, it was concluded that future studies should use separate classification models for buccal mucosa
/ tongue and for gingiva / alveolar mucosa, and notably, a PLS-DA model based only on buccal mucosa
achieved sensitivities and specificities as high as 99% [61].

Figure 6: a) PLS-DA score plot for nuclear spectra from healthy donors (normal) vs patients (lesions),
b) depicting anatomical sites [61].
Field cancerisation, which can result in multiple OPMDs and in second primary tumours and
recurrences, has also been investigated in oral cytology samples [59, 64]. In the studies of pellets of

exfoliated cells, Sahu et al. observed an overlap of spectra of cells from contralateral normal sites and
spectra from cells from tumour sites in oral cancer patients, indicative of field cancerisation [59]. In
the study of Behl et al., oral exfoliated cells were collected from healthy volunteers and from patients
with OPMDs, both from the lesion and from contralateral clinically normal mucosa. The study showed
that the contralateral normal samples could be classified as spectrally different from the healthy
volunteer samples and showed spectral features similar to the lesion samples, particularly in patients
who had developed multiple lesions [64]. The effect of smoking, alcohol consumption, degree of
dysplasia and gender were explored to understand the factors contributing to the spectral overlap
between lesion samples and contralateral normal samples but none of these were found to be
confounding factors.
4. BioFluid analysis:
As an alternative to histological and/or cytological biopsies, bodily fluids (e.g. plasma, serum, saliva
or urine) are emerging as an important source of samples for disease diagnosis and therapeutic
monitoring, as their collection is relatively simple, largely non-invasive, and cost effective [65–69]
and analysis of biofluids using IR and Raman spectroscopies for diagnostic applications has become
increasingly prevalent [70–74]. However, diagnosis based on biofluids does suffer from limitations,
such as low analyte concentration, longer acquisition time, and is prone to experimental errors. In
the case of FTIR spectroscopy, the relatively strong water absorption means that samples are usually
dried before measurement using the Attenuated Total Reflection technique [75], potentially
impacting significantly on the clinical workflow [76]. In the case of Raman spectroscopy, signal
enhancement using nanoparticles or surface coatings is an active area of research [77].
Nevertheless, it has been demonstrated that quantitative evaluation of high and low molecular
weight constituents [78–80], as well as exogenous factors such as viruses [81, 82] and
chemotherapeutic agents [83] can be performed on blood serum, in its native aqueous state [84,
85]. Concentration of samples using centrifugal filtration devices has been shown to allow
measurement of the analytes in the native aqueous environment [86]. This also allows fractionation
according to molecular weight of the constituent analytes, potentially allowing the targeting of
molecular biomarkers of a disease.
Raman spectroscopic analysis of blood samples has also been applied to oral cancer diagnostics. It
has been demonstrated that serum samples from patients that had been diagnosed with buccal
mucosa and tongue cancer can be distinguished from those from healthy volunteers [87]. Amino
acids and lipids were the most significant Raman bands identified in the analysis, and an efficacy of
85% was determined. Raman spectroscopy of serum samples was also able to predict a potential
reoccurrence of oral cancer [87].
In a study of urine samples of healthy subjects and oral cancer patients using Raman spectroscopy, it
was demonstrated that the technique can provide diagnostic discrimination with an accuracy of 94%
[88]. Voided raw urine was collected from 167 patients and spectroscopic evaluation revealed
elevated intensities of features associated with uric acid, specifically C–C stretching at 558 and 649
cm−1 and N–H stretching at 798 cm−1, in cancer patients compared to healthy volunteers. Four
Raman bands related to creatinine also showed increases, while the band at 692 cm−1 was only
present in cancer patients.
Amongst biofluids, saliva has gained increasing interest as a diagnostic fluid, since it represents a
non-invasive, safe and cheap source of complex biomolecular information which can easily be
obtained from the oral cavity [89]. Whole saliva refers to the complex mixture of fluids from the
salivary glands, the gingival crevice, oral mucosa transudate, in addition to mucus of the nasal cavity
and pharynx, non-adherent oral bacteria, food debris, desquamated epithelial and blood cells. Saliva
is composed of more than 99% water. Saliva also contains a variety of electrolytes, including sodium,
potassium, calcium, magnesium, bicarbonate, and phosphates. Also found in saliva are
immunoglobulins, proteins, enzymes, mucins, and nitrogenous products, such as urea and ammonia

[90]. Recent years have seen the development of salivary diagnostic tools to potentially monitor
various oral diseases, ranging from periodontal diseases, dental caries to infections and autoimmune
diseases, although saliva may be used not only to potentially detect oral diseases but also systemic
ones, showing versatility and merit in diagnostic scope. Salivary biomarkers have already shown
promising results in the diagnosis of many diseases, such as periodontitis [91], HIV [92], Hepatitis B
[93], and even measles [94]. Immunoassays have been developed to detect secretory IgA and serumderived IgG (from crevicular fluid) found in saliva for various diseases, as well as saliva has shown
potential for hormone and drug screening [95].
A systematic review of the literature on vibrational spectroscopic analysis of saliva for diagnostic
applications was recently performed by Derruau et al. [96–103]. Of the identified relevant studies,
those relating to oral pathologies were exclusively studied by Raman spectroscopy, and a slightly
earlier review of the literature reporting analysis of saliva samples for the diagnosis of oral cancer by
Calado et al. [104] revealed the literature to be very sparse, and that the majority of studies to date
have been carried out using Surface Enhanced Raman scattering techniques [94]. Values of
sensitivity, specificity and/or classification efficiency higher than 90% were demonstrated for the
diagnosis of OSCC. Peaks/bands associated with salivary components such as proteins, glycoproteins
and lipids were variably identified as potentially associated with the presence of OSCC/oral epithelial
dysplasia in all the studies reviewed. A more recent study examined different sampling
methodologies, including air-dried, lyophilised, pellet and supernatant sampling, and concluded that
the former two forms may be more appropriate for saliva sampling [95]. The method was tested for
classification of oral cancer and healthy subjects (n= 27), yielding 90 % differentiation efficiency.
Notable in the reviews of Derruau et al. [105] and Calado et al. [105] is the inconsistency of the
methodologies employed to date, particularly with regard to the sample collection process. Saliva
can be either stimulated (e.g. by mastication) or non-stimulated, and the contribution of each
salivary gland to, and therefore the average compositions of, each can vary significantly. Raman
analysis of stimulated and non-stimulated saliva from the same donors, however, confirms the
significance of the different compositions [105]. In terms of clinical workflow, however, collection
times for non stimulated saliva (10-15 minutes) are significantly longer than those for stimulated
saliva (2-3 minutes), and so the latter methodology is more favourable for translation to the clinic,
and was utilised for a proof-of-concept study exploring Raman spectroscopy for identification of
OPMDs and OSCC [105]. In a study of saliva samples of 45 OPMD/OSCC patients and 45 normal
volunteer donors, a binary comparison using PLSDA resulted in a sensitivity and specificity of 86%
and 89%, respectively. Efforts to classify the OPMDs vs OSCC groups, and mild/moderate/severe
dysplasia subgroups of OPMD, resulted in significantly lower sensitivity/specificity, although it
should be noted that, as the patient numbers were rather limited, and even more so when
subdivided into grades, the analysis was necessarily performed on very imbalanced data pairs of
subsets which can impact the data analysis protocol. However, using a randomised selection process
to balance the datasets, sensitivity and specificity of 75% and 72% were achieved for classification of
the OPMDs vs OSCC groups [106]. The influence of patient factors and potential confounding factors
on the Raman spectroscopic classification through saliva analysis was also explored in the same
dataset. Partial least squares discriminant analysis did not show any statistical influence of the
gender, age profile or alcohol consumption habits of the groups, although it was noticeable that the
smoker control and patient groups seemed to exhibit a high degree of misclassification, which could
represent a possible confounding factor for the misdiagnosis of smokers as having dysplasia [30].
5. In Vivo:
Although IR spectroscopy provides a detailed fingerprint of the biochemical content of a sample, it
has predominantly been used for the analysis of human tissues ex vivo. Its application to in vivo
diagnosis is limited, because of the short penetration depth and the relatively strong IR absorption
of water in both the fingerprint (~1640 cm-1) and high wavenumber (~3200-3300 cm-1) regions of the

spectrum. Conventional optical fibers have limited transparency in the infrared region, and, although
mid-infrared probes have been explored for in vivo applications [107], Raman spectroscopy is
generally considered a more favourable option for in vivo applications [108]. Using fiber optic
probes, Guze et al. undertook an in vivo Raman spectroscopy study to establish whether the
spectroscopic signatures of normal oral mucosa are reproducible across different anatomic sites and
subjects of different race and gender [109]. Spectroscopic sampling of the; buccal mucosa, gingiva,
dorsal and ventral surfaces of the tongue, floor of the mouth, mucosa of the lower lip, and hard
palate, indicated that different sites are differentiated on the basis of degree of keratinisation.
Bergholt et al. [110] performed a more detailed characterisation of the in vivo Raman spectroscopic
profiles of a similar range of anatomical regions, fitting of the spectra with those of reference
biochemical constituents. The study concluded that the histological and morphological
characteristics of the different sites have a significant influence on the in vivo Raman profiles, and
demonstrated, using partial least squares-discriminant analysis, that the different sites can be
classified with an accuracy of ~85%. Sahu et al. [111] demonstrated that in vivo Raman spectroscopy
methods can also be utilised to understand age-related changes in the oral mucosa. Singh et al. [112]
verified that such in vivo analyses can be performed within clinically feasible timeframes and notably
the potential to differentiate normal and pathologically abnormal regions was demonstrated,
despite the anatomical variability [113], while a further study explored tobacco-induced cancer field
effects in the oral mucosa [114].
Inadequate resection margins in oral cancer surgery increase the likelihood of local recurrence [50].
The use of Raman spectroscopy as an aid in delineation of surgical margins has been explored
extensively in recent years [115], and notably it has been shown that OSCC can be discriminated
from surrounding normal structures with a high degree of accuracy, although it is more likely to
misclassify with surrounding normal and dysplastic epithelium [116]. Water concentration was found
to be higher in tumours compared to the surrounding normal tissue, therefore potentially acting as
an in vivo guide to surgical resection [117]. An in-vivo study by Malik et al. even found that Raman
spectroscopy can predict local recurrence in oral cancers with a sensitivity of 80% and specificity of
30% [118].
6. Discussion and Future Perspectives
In the various areas of potential clinical application, vibrational spectroscopies have been
demonstrated to hold much promise in the identification, diagnosis and treatment of oral cancers, at
least at the proof of concept level. In addition to identification of the presence of disease, the
techniques can potentially differentiate between high grade (moderate/severe dysplasia) and low
grade (no/mild dysplasia) lesions, and between dysplasia and inflammation. It is important to
consider, however, the relative merits of the techniques, and the potential for achieving their
translation. In all cases, both IR absorption and Raman spectroscopies offer the benefits of being
label free, non destructive, and capable of delivering an objective analysis which is based on the
biomolecular composition of the sample, which can be manifest at the early stages of the disease
development, rather than morphological changes, the assessment of which can be subjective, and
manifest only at the later stages of disease progression.
In the case of analysis of tissue biopsies, imaging or mapping of considerably large areas is required,
which is time consuming, and computationally intensive. The former consideration probably favours
the use of IR absorption techniques. The incorporation of Focal Plane Array detectors in FTIR
microscopes enables the simultaneous acquisition of several thousands of spectra [119] and the
more recent emergence of tuneable IR quantum cascade laser spectrometer systems potentially
offers a further step change in data acquisition and processing speeds, which renders the feasibility
of rapid screening of large tissue areas more credible [120]. In comparison, the lower spatial
resolution and/or challenge of the relatively low signal to noise of Raman microspectroscopy makes

it difficult for the technique to rapidly screen large areas. Notably, however, the similarly emerging
techniques of Coherent Raman Scattering (CRS) [121] provide enhancement of signals by several
orders of magnitude and are capable of rapid 3D mapping of bio-molecules with sub-micron
resolution [122]. CRS microscopy can be implemented by recording the coherent anti-Stokes Raman
scattering (CARS) or stimulated Raman scattering (SRS) signal, and both modalities have been
explored for clinical and biological studies[123], including rapid, in-situ label-free acquisition of H&E
like images based on the ratio of Raman signals at 2930 and 2845 cm-1, reflecting the different lipid
and protein contents [124]. The debate on the relative merits of the two techniques for rapid
screening of histological samples continues, therefore. An important consideration in the
applications of such label free techniques to tissue based diagnostics, however, is the observation of
confounding factors of inflammation in the connective tissue, smoking status, and anatomical site.
The higher intrinsic spatial resolution of Raman microspectroscopy makes it more amenable to the
less invasive cytological applications, and the methodologies based on exfoliated cells are readily
adaptable from cervical cytology, which is well established in clinical screening programmes
internationally, with minimal interruption of workflow [125]. The subcellular regions of nucleus and
cytoplasm can be interrogated independently, and it has been observed that they afford
comparable, high degrees of sensitivity and specificity of diagnosis [86]. Cytological based diagnosis
can notoriously lead to false negative results, due to the sparsity of morphologically abnormal cells
on the slide, and consequently low sensitivities [126]. Critically, however, in both cervical [76] and
oral [86] cytological samples, it has been demonstrated that morphologically normal cells exhibit
abnormal Raman spectroscopic signatures which can be associated with early onset of disease,
resulting in significantly increased sensitivities compared to morphologically based cytological
diagnostic tests. Anatomical site was seen to be the most obvious potential confounding factor, but
it was argued that independent multivariate prediction models can be constructed for keratinised
and non-keratinised anatomical regions. The ability to detect and identify field cancerisation
presents the possibility to predict the recurrence of multiple lesions.
Saliva represents an even less invasive “liquid biopsy” which shows potential for oral cancer
diagnostics, and can readily be probed using either IR or Raman spectroscopy. The differences in
diagnostic potential of stimulated and non-stimulated saliva samples has to date not fully been
explored, and critically the relative influences of systemic or localised oral disease on their
biochemical compositions, which could compromise the specificity of the diagnosis, is not yet clear.
Within the context of the increasing application of vibrational spectroscopic techniques for
diagnostic screening of biofluids, IR has the disadvantage that the requirement of drying can
interrupt the clinical workflow [76], although Raman analysis of biofluids also commonly employs a
concentration step, for example through centrifugal filtration [86].
In terms of computational aspects, histopathological applications are probably the most demanding.
Both IR and Raman mapping can generate large datasets, the recording, preprocessing and analysis
of which can take hours [125]. For all applications, however, once a reference database to establish
a predictive model has been, comparative screening of an individual sample is relatively rapid, and
“chairside” in vitro analysis could potentially be performed in quasi realtime. In the case of either
cytological or biofluid based diagnostic applications, a real significant impact would be the ability to
implement the screening in vivo, or “chairside”, as part of a routine dental or oral hygiene check-up,
or post treatment follow up clinics. In terms of initial capital costs, this makes ATR-FTIR a more

attractive alternative to that of Raman. Nevertheless, more compact, less expensive, but
high specification Raman microscopic systems for cytological applications are becoming
increasingly available, and significantly lower cost fiber based options may be a viable

alternative for biofluid analysis, reducing capital costs to ~€10-20k, comparable to those of
compact ATR-FTIR instruments. Of course, the ability of such systems to provide sufficient
sensitivity and specificity would potentially enable routine chairside in vivo screening of oral
lesions and the requirement for invasive biopsies could be reduced . This technology could also
be used to assist in directing the clinician to the most appropriate biopsy site in the case of extensive
oral lesions or for intra-operative assessment of surgical margins.
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